TITLE

Renal Mechanisms

AUTHOR(S)
Andrew, Basil
PUB. DATE
September 1974
SOURCE
British Medical Journal;9/21/1974, Vol. 3 Issue 5933, p748
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64111825

 

Related Articles

  • Doubting Nongenotoxic Mechanisms of Renal Cancer: Comparing Apples and Oranges in the α 2u-Globulin Hypothesis. Dietrich, Daniel R. // Environmental Health Perspectives;Sep1997, Vol. 105 Issue 9, p1 

    Focuses on nongenotoxic mechanisms of renal cancer. Chemical associated with the induction of renal cancer in male rats; Association of gasoline exposure and renal cancer in humans; Treatment options for renal cancer.

  • Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. Attman, Per-Ola; Alaupovic, Petar; Samuelsson, Ola // Kidney International Supplement;Jul1999, Issue 71, pS-14 

    Investigates the role of lipoprotein abnormalities in the development of progressive nondiabetic renal disease. Rate of decline in renal function in relation to high and low levels of apolipoprotein B; Effect of hypolipemic drugs on renal dyslipidemia; Mechanism in the progression of renal...

  • Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. Attman, Per-Ola; Alaupovic, Petar; Samuelsson, Ola // Kidney International Supplement;Jul1999, Issue 71, pS-14 

    Investigates the role of lipoprotein abnormalities in the development of progressive nondiabetic renal disease. Rate of decline in renal function in relation to high and low levels of apolipoprotein B; Effect of hypolipemic drugs on renal dyslipidemia; Mechanism in the progression of renal...

  • Introduction.  // Kidney International Supplement;May1992, Issue 36, pS-1 

    Focuses on chronic renal insufficiency. Mechanisms behind the progression of chronic renal disease; Effects of calcium antagonists on normal renal function; Therapeutic options; Interventions to attenuate progression of chronic renal disease.

  • Mechanisms of renal hemodynamic regulation in response to protein feeding. Woods, Lori L. // Kidney International;Oct1993, Vol. 44 Issue 4, p659 

    Comments on the mechanisms of renal hemodynamic regulation in response to protein feeding. Impact of protein ingestion in the changes in renal hemodynamics; Stimulation of renal vasodilation due to the alteration in renal metabolism; Postulation of both growth hormone and glucagon to mediate the...

  • Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension. Johnson, Richard J.; Herrera-Acosta, Jaime; Schreiner, George F.; Rodríguez-Iturbe, Bernardo // New England Journal of Medicine;3/21/2002, Vol. 346 Issue 12, p913 

    Examines the hypothesis proposed by Fahr and Goldblatt that primary renal microvascular disease may cause hypertension. Idea that acquired renal injury could be a mechanism of salt-sensitive hypertension or a general mechanism of salt sensitivity; Mechanism of renal microvascular and...

  • Renal tumors. Desai, Mihir M.; Gill, Inderbir S. // Contemporary Urology;Sep2002, Vol. 14 Issue 9, p35 

    Examines the principles of cryoablation and the current status of this technique for the treatment of renal tumors. Mechanisms of cryonecrosis; Natural history and histology of the cryolesion; Clinical renal cryoablation.

  • Diabetes and rhabdomyolysis.  // BMJ: British Medical Journal (International Edition);10/30/93, Vol. 307 Issue 6912, p1126 

    Presents a patient developed an acute renal failure secondary to rhabdomyolysis with diabetic hyperosmolarity. Characterization of Rhabdomyolysis; Recognition of acuter renal failure; Discussion on the mechanism causing the disease.

  • No net renal extraction of homocysteine in fasting humans. van Guldener, Coen; Donker, J.M.; Jakobs, Cornelis; Teerlink, Tom; de Meer, Kees; Stehouwer, Coen D.A. // Kidney International;Jul1998, Vol. 54 Issue 1, p166 

    Describes the real extraction of homocysteine in fasting humans. Measurement of plasma and free homocysteine; Mechanism of hyperhomocysteinemia in chronic renal failure; Examination of renal amino acid metabolism.

  • Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy. Woo, K.T.; Lee, G.S.L.; Pall, Abeed A. // Kidney International;Jan2000, Vol. 57 Issue 1, p348 

    Focuses on the management of Immunoglobulin A nephropathy. Potential toxicity mechanisms of cyclophosphamide; Demonstration on the reduction in proteineuria and stabilization of renal function; Apparent loss of benefit on renal function.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics